BDBM328854 (S)-1,1,1-trifluoro-2-methylpropan-2- yl (2- ((chloromethylsulfonamido)methyl)-4- ((4-fluorophenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US9663502, 38N

SMILES CC(C)(OC(=O)Nc1ccc2O[C@@H](CNS(=O)(=O)CCl)CN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(F)(F)F

InChI Key InChIKey=NXKUMQDJVJIWMV-HNNXBMFYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 328854   

TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Lycera

US Patent
LigandPNGBDBM328854((S)-1,1,1-trifluoro-2-methylpropan-2- yl (2- ((chl...)
Affinity DataIC50:  4.18nMAssay Description:The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., a biochemical TR-FRET assay....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent